Kenneth Cunningham

Insider Reports History

Location
London, United Kingdom
Signature
/s/ Andrew Fisher, Attorney-in-fact for Kenneth Cunningham
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth Cunningham:

Company Role Class Num Shares Value Price $ Report Date Ownership
Verona Pharma plc Director Ordinary Shares 0 $0 $106.71 07 Oct 2025 Direct
Verona Pharma plc Director Restricted Share Units 96,000 25 Apr 2025 Direct
Verona Pharma plc Director Restricted Stock Units 72,000 01 Aug 2025 Direct
Verona Pharma plc Director Restricted Share Unit 0 07 Oct 2025 Direct
Verona Pharma plc Director Share Options (Right to Buy) 0 07 Oct 2025 Direct

Insider Reports Filed by Kenneth Cunningham

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VRNA Verona Pharma plc 07 Oct 2025 8 $0 4 Director 08 Oct 2025, 16:31
VRNA Verona Pharma plc 01 Aug 2025 3 -$142,057 4 Director 05 Aug 2025, 20:32
VRNA Verona Pharma plc 25 Apr 2025 1 $0 4 Director 29 Apr 2025, 17:11
VRNA Verona Pharma plc 29 Apr 2024 1 $0 4 Director 30 Apr 2024, 16:16
VRNA Verona Pharma plc 28 Apr 2023 1 $0 4 Director 28 Apr 2023, 16:17
VRNA Verona Pharma plc 28 Apr 2022 1 $0 4 Director 29 Apr 2022, 16:50
VRNA Verona Pharma plc 09 Aug 2021 1 $0 4 Director 10 Aug 2021, 16:43